Nuveen’s Fennec Pharmaceuticals FENC Stock Holding History

Nuveen’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Buy	131,482 +70,534	+116%	+$576K	﹤0.01%	2757
2026 Q1	$375K	Buy	60,948 +34,942	+134%	+$270K	﹤0.01%	2943
2025 Q4	$200K	Hold	26,006	–	–	﹤0.01%	3141
2025 Q3	$243K	Hold	26,006	–	–	﹤0.01%	3106
2025 Q2	$216K	Hold	26,006	–	–	﹤0.01%	3141
2025 Q1	$158K	Hold	26,006	–	–	﹤0.01%	3160
2024 Q4	$164K	Hold	26,006	–	–	﹤0.01%	3233
2024 Q3	$130K	Hold	26,006	–	–	﹤0.01%	3286
2024 Q2	$159K	Hold	26,006	–	–	﹤0.01%	3258
2024 Q1	$289K	Buy	26,006 +1,545	+6%	+$15.5K	﹤0.01%	3109
2023 Q4	$274K	Hold	24,461	–	–	﹤0.01%	3162
2023 Q3	$248K	Hold	24,461	–	–	﹤0.01%	2999
2023 Q2	$304K	Buy	+24,461	New	+$203K	﹤0.01%	3015
2021 Q2	–	Sell	-101,369	Closed	-$630K	–	3426
2021 Q1	$630K	Sell	101,369 -4,680	-4%	-$35.2K	﹤0.01%	3042
2020 Q4	$790K	Buy	106,049 +2,439	+2%	+$18.6K	﹤0.01%	2890
2020 Q3	$628K	Buy	103,610 +27,800	+37%	+$196K	﹤0.01%	2869
2020 Q2	$633K	Buy	+75,810	New	+$564K	﹤0.01%	2811

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Nuveen's FENC Position: Q2 2026 in Review

Nuveen increased its Fennec Pharmaceuticals (FENC) stake by 116% in Q2 2026, buying an estimated $576K and bringing the position to 131,482 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Nuveen first reported a position in FENC in Q2 2020 and has held it in 17 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Nuveen held 131,482 shares of Fennec Pharmaceuticals worth $1.41M as of Q2 2026.
Nuveen bought 70,534 Fennec Pharmaceuticals shares in Q2 2026, an estimated $576K.
Fennec Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2757 holding.
Nuveen first reported a position in Fennec Pharmaceuticals in Q2 2020 and has held it in 17 quarters since.
105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.